| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Medical Department II, Klinikum Grosshadern, University of Munich, D-8000 Munich 70 and Medical Department I, University of Ulm (R.M) D-7900 Ulm, West Germany
Address requests for reprints to: Dr. Rudolf Hoermann, Medical Department II, Klinikum Grosshadern, University of Munich, Marchionistrasse 15, D-8000 Munich 70, West Germany
Previous studies have indicated that the pituitary gland may produce free a-subunit and small quantities of hCG in addition to other glycoprotein hormones. Since synthesis of holo-hCG requires the presence of both subunits, we have investigated the occurrence in human pituitary of free β-subunit of hCG, in addition to intact holo-hCG. We processed a pituitary extract by fractionated ammonium sulfate precipitation followed by sequential chromatography on Sephadex G-100 and Ultrogel AcA 44. The fractions obtained were assessed for their reactivi-ties with a panel of polyclonal and monoclonal antibodies specific for holo-hCG, β-subunit of hCG, 
-subunit, or hCG/LH. In addition to the expected LH and -subunit, we detected materials which eluted from the column in positions very similar to those of cochromatographed 125I-hCG tracer and hCG-β (NIH CR123-β), and which showed immunoreactivity in specific immunoradiometric assays for holo-hCG and hCG-β, respectively. Holo-hCG and hCG-β material derived from the urine of a postmenopausal woman showed behaviors on the column similar to the pituitary forms. Both the pituitary holo-hCG- and free hCG-β-subunit activity could be enriched (
500 times) by affinity chromatography on an hCG antibody-coupled Sepharose column. When subjected to isoelectric focusing in granulated gel holo-hCG and hCG-β-subunit of pituitary origin were focused in the pI-range of pregnancy hCG and pregnancy hCG-β-subunit, respectively. Like pregnancy hCG, most (75%) of the pituitary hCG was bound to a column of Con A-Sepharose; however, the Con A-nonbinding hCG fraction (25%) was much higher than that found in pregnancy hCG. On the basis of immunoreactivites, the content of holo-hCG in our pituitary extract was estimated to be 60 µg/g, and that of free β-subunit 45 µg/g; for comparison, LH was approximately 20 mg/g, and free -subunit 1.6 mg/g. In addition, we could demonstrate the presence of both holo-hCG- and free hCG-β-subunit-like immunoreactivity in NaCl-extracts from single pituitaries of two postmenopausal women. In these studies a second hCG-β-immunoreactive material eluting far behind the hCG-β-position was found. Chromatography of purified LH-β-subunit, which crossreacts 1.56% in the hCG-β IRMA, yielded an elution pattern clearly distinguishable from that of the hCG-β-immunoreactive substances. Spiking of the pituitary extract with hCG-β and a β-fragment of hCG similar to the so-called β-core fragment resulted in a rise of the first and second hCG-β-activity peak, respectively.Taken together, the immunological and the various chromatographic studies provide strong evidence for the existence of both free hCG-β-subunit and holo-hCG in the human pituitary gland. The properties of hCG- and hCG-β-like materials found in the human pituitary compared favorably with those of the respective purified standard preparations of pregnancy sources and of urinary material from a postmenopausal woman. Apparently, the human pituitary is able to produce both an -subunit, which has been well recognized, and an hCG-β-subunit as described in this report, and to assemble the two subunits to produce holo-hCG.
Received March 3, 1989.
This article has been cited by other articles:
 |
|
 |
|
  A. Henke, C. Marc Luetjens, M. Simoni, and J. Gromoll Chorionic Gonadotropin {beta}-Subunit Gene Expression in the Marmoset Pituitary Is Controlled by Steroidogenic Factor 1, Early Growth Response Protein 1, and Pituitary Homeobox Factor 1 Endocrinology, December 1, 2007; 148(12): 6062 - 6072. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. L Buckner, L. Wilson, and C. N. Papadea An Unusual Cause of Elevated Serum Total {beta}hCG Ann. Clin. Lab. Sci., January 1, 2007; 37(2): 186 - 191. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. M. Garone, E. Ammannati, T. S. Brush, D. J. Fischer, E. G. Tos, J. Luo, K. L. Altobello, C. Ciampolillo, T. M. Ihley, E. Kurosawa, et al. Biological Properties of a Novel Follicle-Stimulating Hormone/Human Chorionic Gonadotropin Chimeric Gonadotropin Endocrinology, September 1, 2006; 147(9): 4205 - 4212. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. A. Cole "Background" Human Chorionic Gonadotropin in Healthy, Nonpregnant Women Clin. Chem., October 1, 2005; 51(10): 1765 - 1766. [Full Text] [PDF]
|
|
|
|
|
|
J. A. Snyder, S. Haymond, C. A. Parvin, A. M. Gronowski, and D. G. Grenache Diagnostic Considerations in the Measurement of Human Chorionic Gonadotropin in Aging Women Clin. Chem., October 1, 2005; 51(10): 1830 - 1835. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. M. Moulton, P. H. Yoshihara, D. H. Mason, P. L. Iversen, and P. L. Triozzi Active Specific Immunotherapy with a {beta}-Human Chorionic Gonadotropin Peptide Vaccine in Patients with Metastatic Colorectal Cancer: Antibody Response Is Associated with Improved Survival Clin. Cancer Res., July 1, 2002; 8(7): 2044 - 2051. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. K. Iles, M. K. Javid, L. K. Gunn, and T. Chard Cross-Reaction with Luteinizing Hormone ß-Core Is Responsible for the Age-dependent Increase of Immunoreactive ß-Core Fragment of Human Chorionic Gonadotropin in Women with Nonmalignant Conditions Clin. Chem., April 1, 1999; 45(4): 532 - 538. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Kovalevskaya, S. Birken, T. Kakuma, J. Schlatterer, and J. F. O'Connor Evaluation of Nicked Human Chorionic Gonadotropin Content in Clinical Specimens by a Specific Immunometric Assay Clin. Chem., January 1, 1999; 45(1): 68 - 77. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. A. Cole Immunoassay of human chorionic gonadotropin, its free subunits, and metabolites Clin. Chem., December 1, 1997; 43(12): 2233 - 2243. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U.-H. Stenman, L. Unkila-Kallio, J. Korhonen, and H. Alfthan Immunoprocedures for detecting human chorionic gonadotropin: clinical aspects and doping control Clin. Chem., July 1, 1997; 43(7): 1293 - 1298. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Moncayo and H. E Moncayo A new endocrinological and immunological syndrome in SLE: elevation of human chorionic gonadotropin and of antibodies directed against ovary and endometrium antigens Lupus, February 1, 1995; 4(1): 39 - 45. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
